Stock listing
PLRX Stock Price, News, Filings & Events — Pliant Therapeutics, Inc.
Selected listing: PLRX · NASDAQ · USD · US
This page tracks Pliant Therapeutics, Inc.'s PLRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLRX:NASDAQ. PLRX:NASDAQ is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pliant Therapeutics, Inc. is a public company traded under the ticker PLRX on the American market. The company has a market capitalization of approximately $67.5 million. Pliant focuses on developing innovative therapies for fibrotic diseases, aiming to address significant unmet medical needs.
- Ticker
- PLRX:NASDAQ
- Asset type
- Stock
- Market cap
- $72.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Pliant Therapeutics, Inc. PLRX:NASDAQ stock context
This page tracks Pliant Therapeutics, Inc.'s PLRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLRX:NASDAQ. PLRX:NASDAQ is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pliant Therapeutics, Inc. is a public company traded under the ticker PLRX on the American market. The company has a market capitalization of approximately $67.5 million. Pliant focuses on developing innovative therapies for fibrotic diseases, aiming to address significant unmet medical needs.
Latest news from Pliant Therapeutics, Inc.
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refract...
August 18, 2026
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 11, 2026
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors
July 13, 2026
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 11, 2026
Research Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for PLRX:NASDAQ.
Pliant Therapeutics, Inc. company profile
View the public company page for Pliant Therapeutics, Inc. on 6ix.
Pliant Therapeutics, Inc. news
Read company news and market updates connected to Pliant Therapeutics, Inc..
Pliant Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Pliant Therapeutics, Inc..
Alternate listings
A2P4YV:LSX
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
A2P4YV:LS
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
PLRX:BOATS
US · USD
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
9PT:GETTEX
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
9PT:DUS
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
9PT:FWB
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
9PT:MUN
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
9PT:SWB
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.
9PT:TRADEGATE
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is PLRX:NASDAQ.